Veeva Systems (VEEV)
NYSEHealth CareSoftware - ApplicationSnapshot 2026-09-04
$275.09-3.27%
Close 2026-09-04 · 1-day change
NYSEHealth CareSoftware - ApplicationSnapshot 2026-09-04
QuarterlyIQ Insights · VEEV
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||
| Revenues | 3,458.1 | 3,195.3 | 2,746.6 | 2,363.7 | 2,155.1 | 1,850.8 | 1,465.1 | 1,104.1 | 862.2 | 690.6 | 550.5 | 409.2 | 313.2 | 210.2 |
| Total Revenues | — | — | — | — | — | — | — | 1,104.1 | 862.2 | 690.6 | 550.5 | 409.2 | 313.2 | 210.2 |
| Cost of Revenues | 865.9 | 782.0 | 699.6 | 677.3 | 609.4 | 503.7 | 408.9 | 303.4 | 245.3 | 211.4 | 173.7 | 142.2 | 115.7 | 82.6 |
| Gross Profit | 2,592.2 | 2,413.3 | 2,047.0 | 1,686.4 | 1,545.7 | 1,347.1 | 1,056.1 | 800.7 | 616.9 | 479.1 | 376.9 | 267.0 | 197.6 | 127.5 |
| Operating Expenses & Income | ||||||||||||||
| R&D Expenses | 821.9 | 767.4 | 693.1 | 629.0 | 520.3 | 382.0 | 294.2 | 209.9 | 158.8 | 132.0 | 96.7 | 66.0 | 41.2 | 26.3 |
| Operating Income | 1,034.9 | 916.4 | 691.4 | 429.3 | 459.1 | 505.5 | 377.8 | 286.2 | 222.9 | 157.9 | 120.7 | 78.6 | 70.0 | 39.3 |
| Earnings from Continuing Operations | ||||||||||||||
| EBT, Incl. Unusual Items | 1,327.4 | 1,194.5 | 919.4 | 588.0 | 509.1 | 512.3 | 394.0 | 313.7 | 238.6 | 165.8 | 122.4 | 78.6 | 67.2 | 38.5 |
| Income Tax Expense | 312.6 | 285.6 | 205.2 | 62.3 | 21.4 | 84.9 | 14.0 | 12.6 | 8.8 | 14.6 | 44.8 | 24.2 | 26.8 | 14.9 |
| Net Income | ||||||||||||||
| Net Income | 1,014.8 | 908.9 | 714.1 | 525.7 | 487.7 | 427.4 | 380.0 | 301.1 | 229.8 | 151.2 | 77.6 | 54.5 | 40.4 | 23.6 |
| Per Share | ||||||||||||||
| Basic EPS | 6.25 | 5.55 | 4.41 | 3.27 | 3.14 | 2.79 | 2.52 | 2.04 | 1.59 | 1.08 | 0.57 | 0.41 | 0.31 | 0.20 |
| Diluted EPS | 6.15 | 5.44 | 4.32 | 3.22 | 3.00 | 2.63 | 2.36 | 1.90 | 1.47 | 0.98 | 0.53 | 0.38 | 0.28 | 0.15 |
| Revenue per Share | 20.95 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 162.3 | 163.7 | 161.9 | 160.5 | 155.4 | 153.3 | 150.7 | 147.8 | 144.2 | 140.3 | 135.7 | 132.0 | 127.7 | 51.7 |
| Diluted Weighted Avg Shares | 165.1 | 167.0 | 165.2 | 163.5 | 162.4 | 162.3 | 160.7 | 158.3 | 156.1 | 153.7 | 147.6 | 145.0 | 144.2 | 68.0 |
| Supplemental | ||||||||||||||
| EBITDA | — | — | — | — | — | — | — | 306.1 | 236.9 | 172.2 | 134.5 | 87.1 | 73.9 | 41.7 |
| EBIT | 1,034.9 | 916.4 | 691.4 | 429.3 | 459.1 | 505.5 | 377.8 | 286.2 | 222.9 | 157.9 | 120.7 | 78.6 | 70.0 | 39.3 |
| Effective Tax Rate | 23.6% | — | — | — | 4.2% | 16.6% | 3.6% | 4.0% | 3.7% | 8.8% | 36.6% | 30.7% | 39.9% | 38.7% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.